Hepatitis C Medication Price War

January 10, 2015 8:20 PM

13 0

Business is clearly business! This is proved by the only hepatitis C drug makers in the market, AbbVie Inc. and Gilead Sciences Inc. have now officially engaged in the price war, despite making a statement last year claiming that they were not planning to get into the 2015 price war. Now, they have started to offer consistent discounts to health insurance providers across the United States towards their products.

The great news for several victims of hepatitis C was when the company started offering substantial discounts on many of their products all throughout the States. Anthem Inc is one of the most important health insurance and said recently let out the news that it successfully completed a deal with on...

Also read: Teva to sell women's health assets to CVC Capital Partners: report

Read more

To category page

Loading...